PDCD1 and plasma cell myeloma: Myeloma cells offer high levels of PD-L1 to PD-1-expressing T and NK cells in the TME (43–45), and in vitro studies showed enhanced myeloma cell killing by T and NK cells after PD-1 and/or PD-L1 blockade (46).